Temporal trends in transcatheter and surgical aortic valve replacement: An analysis of aortic valve replacements in Germany during 2012–2014;Ergebnisse nach kathetergestützten und chirurgischen Aortenklappenimplantationen: Eine Analyse der Aortenklappenimplantationen in Deutschland von 2012 bis 2014

Herz

Volumn 42, Issue 3, 2017, Pages 316-324

  Gaede, L ^a,c   Kim, W K ^b   Blumenstein, J ^a   Liebetrau, C ^b   Dorr O ^d   Nef, H ^d   Hamm, C ^b,d   Walther, T ^b   Achenbach, S ^c   Elsasser A ^e   Mollmann H ^a  

^a ST JOHANNES HOSPITAL   (Germany)

^b Kerckhoff Heart and Thorax Center ^*  (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e KLINIKUM OLDENBURG   (Germany)

Author keywords

Aortic valve stenosis; Germany; Mortality; Outcome; Transcatheter aortic valve replacement

Indexed keywords

AGE DISTRIBUTION; AORTIC VALVE REPLACEMENT; AORTIC VALVE STENOSIS; ARTICLE; CARDIOVASCULAR RESPONSE; COMORBIDITY; DISEASE SEVERITY; GERMANY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PREVALENCE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; ADULT; AGED; ANNULOPLASTY; CLINICAL PRACTICE; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; HEART VALVE PROSTHESIS; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS; UTILIZATION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC VALVE ANNULOPLASTY; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84982937224     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-016-4461-1     Document Type: Article

References (28)

1. Eggebrecht H, Mehta RH (2015) Transcatheter aortic valve implantation (TAVI) in Germany 2008–2014: on its way to standard therapy for aortic valve stenosis in the elderly? EuroIntervention 11(9):1029–1033. doi:10.4244/eijy15m09_11
2. Lefèvre T, Kappetein AP, Wolner E et al (2011) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148–157. doi:10.1093/eurheartj/ehq427
3. Smith C, Leon M, Mack M et al (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364(23):2187–2198
4. Hamm CW, Möllmann H, Holzhey D et al (2014) The German Aortic Valve Registry (GARY): In-hospital outcome. Eur Heart J 35:1588–1598
5. Kapadia SR, Leon MB, Makkar RR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2485–2491
6. Mack MJ, Leon MB, Smith CR et al (2015) 5‑year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 385(9986):2477–2484
7. Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 33:2451–2496
8. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. doi:10.1056/NEJMoa1514616
9. Adams DH, Popma JJ, Reardon MJ (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 371:967–968
10. Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis – complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105(6):553–559
11. AQUA-Institut (2014) Ausfüllhinweise Herzchirurgie (HCH). https://www.sqg.de/downloads/2014/V06/Ausfuellhinweise/Ausfuellhinweise_HCH.htm (Created 28 January 2014)
12. https://www.sqg.de/front_content.php
13. Parolari A, Pesce LL, Trezzi M et al (2010) EuroSCORE performance in valve surgery: a meta-analysis. Ann Thorac Surg 89:787–793.e2
14. Kötting J, Schiller W, Beckmann A et al (2013) German aortic valve score: a new scoring system for prediction of mortality related to aortic valve procedures in adults. Eur J Cardiothorac Surg 43:971–977
15. Gummert J, Funkat A, Osswald B et al (2009) EuroScore overestimates the risk of cardiac surgery: results from the national registry of the German Society of Thoracic and Cardiovascular Surgery. Clin Res Cardiol 98:363–369
16. Nilsson J, Algotsson L, Höglund P et al (2006) Comparison of 19 pre-operativ risk stratification models in open-heart surgery. Eur Heart J 27:867–874
17. Durand E, Borz B, Godin M et al (2013) Performance analysis of EuroSCORE II compared to the original logistic EuroSCORE and STS scores for predicting 30-day mortality after transcatheter aortic valve replacement. Am J Cardiol 111:891–897
18. Leon M, Smith C, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607
19. Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76
20. Popma JJ, Adams DH, Reardon MJ et al (2014) Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 63:1972–1981
21. Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30:74–80
22. Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496
23. Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751
24. Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.034
25. Adams DH, Popma JJ, Reardon MJ et al (2014) Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 370:1790–1798
26. Thyregod HGH, Steinbrüchel DA, Ihlemann N et al (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: one-year results from the all-comers nordic aortic valve intervention (NOTION) randomized clinical trial. J Am Coll Cardiol. doi:10.1016/j.jacc.2015.03.014
27. Rosenhek R, Iung B, Tornos P et al (2012) ESC working group on valvular heart disease position paper: assessing the risk of interventions in patients with valvular heart disease. Eur Heart J 33:822–828
28. Sedaghat A, Sinning J‑M, Vasa-Nicotera M et al (2013) The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation. Clin Res Cardiol 102:821–829